TY - JOUR ID - TI - Current therapeutic protocols for COVID-19 and promising nanotechnology solution AU - Salim Albukhaty سالم نعمة صالح البخاتي AU - Hassan Al-Karagoly حسن خلف عليوي القره غولي AU - Sharafaldin Al-Musawi شرف الدين الموسوي AU - Haydar Abood حيدر كريم عبود PY - 2020 VL - 19 IS - المؤتمر الافتراضي الأول – ملحق 38 SP - 1047 EP - 1067 JO - Misan Journal of Academic Studies مجلة ميسان للدراسات الاكاديمية SN - 1994697X 2706722X AB - The global health crisis of novel coronavirus disease (COVID-19), that is caused by SARS-CoV-2 a new virus recently discovered in Hunan Seafood market located in Wuhan, Hubei Province; China in December 2019, that resulted in severe acute respiratory infections, with critical complications among old and who are immunosuppressed people. There are common drugs usually available for reducing complications, however; resistance to those drugs has been developed by (SARS-CoV-2) virus, which leads to a remarkable loss of efficiency of these medicines. in this regard, applications of nanotechnology appear to extremely exhibit excellent options to solve this problem. This review investigates the currently available drugs and alternative drugs used for the potential therapy of (COVID-19) symptoms with focusing on nanotechnology to address this pandemic.

ER -